Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Target-controlled dexmedetomidine concentration during moderate sedation in elderly patients under intraspinal anesthesia
ChiCTR2200063123Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine (2 arms), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoints: Bispectral index (BIS), Modified Observer's Assessment of Alertness/Sedation (MOAA/S) score and 2 more. Started Sep 2022; status: recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ChiCTR2200063123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063123.